Skip to content

To see the effect Of Panchasama churna and Shatpushpadhya churna and compare their action in the treatment of Aamvata with reference to Rheumatoid arthritis.

A RANDOMIZED CLINICAL TRIAL TO COMPARE THE EFFICIENCY OF PANCHASAMA CHURNA AND SHATPUSHPADYA CHURNA IN THE MANAGEMENT OF AMAVATA W.S.R.TO RHEUMATOID ARTHRITIS. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/101005
Enrollment
60
Registered
2026-01-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement

Interventions

None listed

Sponsors

Dr VJD Gramin Ayurveda Mahavidyalaya Patur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients who are willing for clinical trial. 2) Patients have signs and symptoms of Amavata. 3) The patients of the age group 20 to 60 years will be selected. 4) The patients will be selected irrespective of sex & religion. 5) RA test positive patients

Exclusion criteria

Exclusion criteria: 1) Patients who are not willing for clinical trial. 2) Age is less than 20 years and more than 60 years. 3) Chronicity more than 5 yr. 4) Any severe deformity. 5) Pregnant woman, lactating mothers. 6) Other major illnesses like HIV, AIDS, TB, HTN DM and malignancy

Design outcomes

Primary

MeasureTime frame
1. Sandhishool-Vruschikdanshavat vedana 2. Sandhishotha 3. Sandhistabdhata 4. Sandhisparshasahatva 5. Jwar will be decreasedTimepoint: After 15 days,30 daya,45 days from starting of treatment

Secondary

MeasureTime frame
Decreasing overall symptomsTimepoint: 18 months

Countries

India

Contacts

Public ContactDr Jayshree Katole

Dr. VJD Gramin Ayurveda Mahavidyalaya

drjrkatole@gmail.com9423847608

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026